PROGRAM EVALUATION Please provide the following information: FIRST NAME LAST NAME PROFESSION PhysicianOther SPECIALTY EndocrinologyGeneral MedicineInternal/Family MedicineOphthalmologyOptometryOther COUNTRY Please SelectAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArctic OceanArubaAshmore and Cartier IslandsAtlantic OceanAustraliaAustriaAzerbaijanBahamasBahrainBaker IslandBangladeshBarbadosBassas da IndiaBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandClipperton IslandCocos IslandsColombiaComorosCook IslandsCoral Sea IslandsCosta RicaCote d'IvoireCroatiaCubaCyprusCzech RepublicDenmarkDemocratic Republic of the CongoDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaEuropa IslandFalkland Islands (Islas Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern and Antarctic LandsGabonGambiaGaza StripGeorgiaGermanyGhanaGibraltarGlorioso IslandsGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHondurasHong KongHowland IslandHungaryIcelandIndiaIndian OceanIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJan MayenJapanJarvis IslandJerseyJohnston AtollJordanJuan de Nova IslandKazakhstanKenyaKingman ReefKiribatiKerguelen ArchipelagoKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMidway IslandsMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNavassa IslandNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorth SeaNorthern Mariana IslandsNorwayOmanPacific OceanPakistanPalauPalmyra AtollPanamaPapua New GuineaParacel IslandsParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarReunionRepublic of the CongoRomaniaRussiaRwandaSaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSpainSpratly IslandsSri LankaSudanSurinameSvalbardSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTromelin IslandTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUSAUruguayUzbekistanVanuatuVenezuelaViet NamVirgin IslandsWake IslandWallis and FutunaWest BankWestern SaharaYemenYugoslaviaZambiaZimbabwe E-MAIL Question 1: Please rate the presentations according to the following scale by choosing the appropriate numbers in the table below. Diabetic Retinopathy and the Evolution of Eye Screening Technology David Kerr, MB, ChB, DM, FRCPE, FRCP Was the topic selected appropriate for the audience? Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Relevance to My Practice Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Balanced and Without Commercial Interest Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Was the presentation clear, organized and understandable? Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree The New Science of AI Screening Jennifer I Lim, MD, FARVO Was the topic selected appropriate for the audience? Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Relevance to My Practice Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Balanced and Without Commercial Interest Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Was the presentation clear, organized and understandable? Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree AI Screening in Practice: Implementation Data and Endpoints Steven Yeh, MD, FASRS Was the topic selected appropriate for the audience? Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Relevance to My Practice Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Balanced and Without Commercial Interest Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Was the presentation clear, organized and understandable? Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Presentation /Speaker Question & Answer Session All faculty Was the topic selected appropriate for the audience? Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Relevance to My Practice Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Balanced and Without Commercial Interest Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Was the presentation clear, organized and understandable? Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Question 2: Please indicate how well you think the learning objectives were covered according to the following scale by choosing the appropriate numbers in the table below. Learning Objective 1 Gain a better understanding of the latest knowledge of diabetic retinopathy and the evolution of eye screening technology Objective Was Met Please Rate1-Poor2-Fair3-Satisfactory4-Good5-Excellent Confidence in Personal Ability to Achieve the Objective BEFORE the Presentations Please Rate1-Poor2-Fair3-Satisfactory4-Good5-Excellent Confidence in Personal Ability to Achieve the Objective AFTER the Presentations Please Rate1-Poor2-Fair3-Satisfactory4-Good5-Excellent Learning Objective 2 Learn about the new science, advances, and benefits of Artificial Intelligence eye screening Objective Was Met Please Rate1-Poor2-Fair3-Satisfactory4-Good5-Excellent Confidence in Personal Ability to Achieve the Objective BEFORE the Presentations Please Rate1-Poor2-Fair3-Satisfactory4-Good5-Excellent Confidence in Personal Ability to Achieve the Objective AFTER the Presentations Please Rate1-Poor2-Fair3-Satisfactory4-Good5-Excellent Learning Objective 3 Obtain practical knowledge into how AI screening is being implemented in practice based on clinical data results Objective Was Met Please Rate1-Poor2-Fair3-Satisfactory4-Good5-Excellent Confidence in Personal Ability to Achieve the Objective BEFORE the Presentations Please Rate1-Poor2-Fair3-Satisfactory4-Good5-Excellent Confidence in Personal Ability to Achieve the Objective AFTER the Presentations Please Rate1-Poor2-Fair3-Satisfactory4-Good5-Excellent Question 3: Did this program increase or expand your knowledge of the topics presented by the speakers? Please Rate1-Totally disagree2-Disagree3-Indifferent4-Agree5-Totally agree Question 4: Based on the information presented, do you intend to apply the knowledge gained to your clinical practice? YesNo Please explain your answer. Question 5: Please include any other comments you may have, including suggestions for future programs. This program is sponsored by the Worldwide Initiative for Diabetes Education and supported by an educational grant from Eyenuk, Inc. A Worldwide Initiative for Diabetes Education for Health Care Professionals